HillSignal

TICKER INTELLIGENCE

Regeneron Pharmaceuticals, Inc. ($REGN)

$631.81 2.2% (7d)

NYSE/NASDAQ: REGN

Washington Intelligence

3

Active Bills

0

Gov't Contracts

50

Congressional Trades

Regeneron is a publicly traded company in the Technology sector. This company operates across Technology and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 3 active Congressional signals mentioning Regeneron, including 3 bills. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.

Congressional Trades in $REGN

50 filings
Gilbert Cisneros
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

Rep. Cisneros bought $1K-$15K in CRWD on May 15, 2026 — 5 days before HR8880 (a bill boosting cybersecurity for small businesses) was introduced.

2026-06-08
7 flags
Ro Khanna
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No overlapping signals found

2026-05-13
1 flag
Julia Letlow
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No overlapping signals found

2026-03-13
1 flag
Julia LetlowR-LA
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

Rep. Letlow bought $1,001 - $15,000 in TSM on 2026-02-02 — 8 days before the Taiwan Energy Security and Anti-Embargo Act of 2026 (S2722) advanced to the Senate Legislative Calendar, a bill that could impact semiconductor supply chains.

2026-03-12
4 flags
Gilbert Cisneros
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock

System: No suspicious timing patterns detected

2025-12-15
1 flag
Ro Khanna
SELL $1,001 - $15,000 — REGENERON PHARMACEUTICAL INC CMN

System: No suspicious timing patterns detected

2025-10-03
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2025-09-12
1 flag
Rob Bresnahan
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2025-06-10
1 flag
Rob BresnahanR-PA
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. Common Stock (REGN)

Rob Bresnahan bought $1,001 - $15,000 in NVDA on May 12, 2025, May 13, 2025, and May 16, 2025 — 6 to 10 days before the Access Technology Affordability Act of 2025 (S1918) was introduced, a bill that could benefit the company.

2025-06-09
5 flags
Byron Donalds
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals Inc
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2025-05-26
1 flag
Byron DonaldsR-FL
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

Rep. Donalds bought $1,001 - $15,000 in V (Visa Inc.) on 2025-04-10, 102 days before the Small Nonprofit Retirement Security Act of 2025 (HR4548) was introduced. This bill is described as having a bullish impact and aligned coherence with the trade.

2025-05-24
2 flags
Rob Bresnahan
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock

System: No suspicious timing patterns detected

2025-05-08
1 flag
Rob Bresnahan
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2025-03-28
1 flag
Julie Johnson
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2025-03-13
1 flag
Julie JohnsonD-TX
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST]

Representative Johnson sold $15,001 - $50,000 in TSLA on 2025-02-12 and $1,001 - $15,000 in TSLA on 2025-02-11 — 9 and 10 days before the "Unplug the Electric Vehicle Charging Stations Program Act" (HR1513) was introduced, a bill seeking to eliminate federal funding for EV charging infrastructure.

2025-03-12
3 flags
Julie JohnsonD-TX
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST]

Rep. Johnson bought $1K-$15K in MRK on Jan 17, 2025 — 35 days before HR1492 was introduced, a bill extending Medicare price-negotiation protections for small-molecule drugs like those from Merck.

2025-02-12
5 flags
Julie Johnson
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock

System: No suspicious timing patterns detected

2025-02-12
1 flag
Josh Gottheimer
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2025-02-11
1 flag
Josh GottheimerD-NJ
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

Rep. Gottheimer made two purchases of Mastercard (MA) totaling $2,002-$30,000 on Jan 30-31, 2025 — 5-6 days before the Fair Access to Banking Act (HR987) was introduced, a bill directly regulating bank and payment network standards.

2025-02-10
5 flags
Jonathan JacksonD-IL
SELL $15,001 - $50,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST]
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST]

Rep. Jackson purchased $15K-$50K in AMZN on Nov 27, 2024 — 71 days before HR1062 (Growing and Preserving Innovation in America Act) was introduced, a bill that permanently locks in higher tax deductions for US multinationals like Amazon.

2024-12-12
2 flags
Jonathan Jackson
SELL $15,001 - $50,000 — Regeneron Pharmaceuticals, Inc. - Common Stock
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock

System: No suspicious timing patterns detected

2024-12-12
1 flag
Josh GottheimerD-NJ
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST]
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST]

Rep. Gottheimer bought $1K-$15K in JNJ on Nov 22 and Nov 26, 2024 — 72-76 days before HR1062 (Growing and Preserving Innovation in America Act) was introduced, a bill that permanently locks in higher tax deductions for US multinationals like JNJ.

2024-12-05
4 flags
Josh Gottheimer
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock

System: No suspicious timing patterns detected

2024-12-05
1 flag
Greg LandsmanD-OH
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST]

Rep. Landsman sold $15K-$50K in Exxon Mobil (XOM) on Oct 15, 2024 — 113 days before the No Tax Breaks for Outsourcing Act (S409) was introduced, a bill that would increase taxes on multinationals like Exxon.

2024-11-14
2 flags
Greg Landsman
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock

System: No suspicious timing patterns detected

2024-11-14
1 flag
Josh Gottheimer
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2024-11-07
1 flag
Josh GottheimerD-NJ
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

Rep. Gottheimer sold $15K-$50K in MSFT on Oct 2, 2024 and $1K-$15K in MSFT on Oct 3, 2024 — 37-38 days after a $66.8M Deloitte VA cybersecurity contract was announced. While Deloitte is a Microsoft partner, the trade timing is notable for occurring just over a month after a major government contract that could affect the broader tech consulting ecosystem.

2024-11-06
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2024-10-08
1 flag
Josh Gottheimer
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock

System: No suspicious timing patterns detected

2024-08-15
1 flag
Josh GottheimerD-NJ
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

System: No suspicious timing patterns detected

2024-08-15
1 flag
Greg LandsmanD-OH
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

Rep. Landsman bought $1K-$15K in AMZN on June 3, 2024 — 59 days before Four Points Technology received a $150M Social Security Administration contract that directly benefits Amazon as the cloud provider.

2024-08-14
3 flags
Greg Landsman
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock

System: No suspicious timing patterns detected

2024-08-14
1 flag
Tommy Tuberville
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock

System: No suspicious timing patterns detected

2024-05-15
1 flag
Josh GottheimerD-NJ
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

System: No suspicious timing patterns detected

2024-03-07
1 flag
Josh Gottheimer
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock

System: No suspicious timing patterns detected

2024-03-07
1 flag
Jonathan JacksonD-IL
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

System: No suspicious timing patterns detected

2024-02-15
1 flag
Jonathan Jackson
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. - Common Stock

System: No suspicious timing patterns detected

2024-02-15
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2024-02-05
1 flag
Josh Gottheimer
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2023-12-08
1 flag
Josh GottheimerD-NJ
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. (REGN) [ST]

System: No suspicious timing patterns detected

2023-12-08
1 flag
Rohit KhannaD-CA
BUY $1,001 - $15,000 — REGENERON PHARMACEUTICAL INC CMN

System: No suspicious timing patterns detected

2023-12-06
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2023-12-06
1 flag
Ro Khanna
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2023-11-08
1 flag
Josh GottheimerD-NJ
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. (REGN) [ST]

System: No suspicious timing patterns detected

2023-09-16
1 flag
Ro Khanna
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals Inc
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2023-09-06
1 flag
Josh Gottheimer
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. (REGN)

System: No suspicious timing patterns detected

2023-08-21
1 flag
Josh GottheimerD-NJ
BUY $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. (REGN) [ST]

System: No suspicious timing patterns detected

2023-08-21
1 flag
Ro Khanna
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals Inc

System: No suspicious timing patterns detected

2023-08-07
1 flag
Josh GottheimerD-NJ
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. (REGN) [ST]

System: No suspicious timing patterns detected

2023-07-11
1 flag
Josh Gottheimer
SELL $1,001 - $15,000 — Regeneron Pharmaceuticals, Inc. (REGN)

System: No suspicious timing patterns detected

2023-07-11
1 flag

Congressional Legislation Affecting Regeneron Pharmaceuticals, Inc. ($REGN)

HR6624 forces a structural onshoring of U.S. synthetic biology IP and manufacturing away from PRC entities. Domestic pure-plays Ginkgo Bioworks ($DNA) and Twist Bioscience ($TWST) are direct beneficiaries, while large biopharma Amgen ($AMGN) and Regeneron ($REGN) face near-term capex pressure but reduced long-term IP risk. The bill advanced out of committee with bipartisan support and has an identical Senate companion bill, increasing passage probability.

Near-term supply chain disruption risk and cost to transition manufacturing; long-term IP protection benefit offsets

HR6624

HR6052, the Elijah E. Cummings Family Asthma Act, is an early-stage bill that amends the Public Health Service Act to direct further asthma research. It authorizes no specific funding, mandates no changes to healthcare providers or pharmaceutical companies, and has been referred to committee with four cosponsors. No near-term market impact is expected.

HR6052

The Small Biotech Innovation Act (HR3731) is an early-stage bill that would exempt R&D-intensive small biotech manufacturers (≤5 qualifying drugs) from Medicare drug price negotiations starting in 2029. The bill is in committee with no floor action, and no market reaction is evident from provided data. The legislative path is long and uncertain — this is a structural watch item, not a trading catalyst.

Shields qualifying small biotech drugs from mandatory Medicare price negotiation, preserving revenue streams for those drugs

HR3731

Understanding These Signals

Get Full Access to Regeneron Pharmaceuticals, Inc. ($REGN) Signals

Daily AI-analyzed alerts for Congressional activity affecting your portfolio.

Get Started →